Donald E. Cutlip

1998–2025 年に発表

別表記
Donald E Cutlip
122
論文数
51,330
被引用数
88
h 指数
119
i10 指数

被引用数

Donald E. Cutlip の年別被引用数1996 年: 被引用 5 件1998 年: 被引用 6 件1999 年: 被引用 19 件2000 年: 被引用 31 件2001 年: 被引用 39 件2002 年: 被引用 38 件2003 年: 被引用 57 件2004 年: 被引用 83 件2005 年: 被引用 159 件2006 年: 被引用 140 件2007 年: 被引用 224 件2008 年: 被引用 244 件2009 年: 被引用 245 件2010 年: 被引用 253 件2011 年: 被引用 410 件2012 年: 被引用 414 件2013 年: 被引用 367 件2014 年: 被引用 316 件2015 年: 被引用 388 件2016 年: 被引用 327 件2017 年: 被引用 294 件2018 年: 被引用 277 件2019 年: 被引用 1,096 件2020 年: 被引用 1,147 件2021 年: 被引用 939 件2022 年: 被引用 670 件2023 年: 被引用 529 件2024 年: 被引用 932 件2025 年: 被引用 388 件2026 年: 被引用 21 件1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,278 件、この内訳の 19.9%ドイツ: 引用元論文 1,201 件、この内訳の 7.3%イタリア: 引用元論文 1,195 件、この内訳の 7.2%イギリス: 引用元論文 1,162 件、この内訳の 7%オランダ: 引用元論文 876 件、この内訳の 5.3%フランス: 引用元論文 816 件、この内訳の 4.9%カナダ: 引用元論文 767 件、この内訳の 4.6%スイス: 引用元論文 616 件、この内訳の 3.7%日本: 引用元論文 592 件、この内訳の 3.6%中国: 引用元論文 539 件、この内訳の 3.3%スペイン: 引用元論文 539 件、この内訳の 3.3%ベルギー: 引用元論文 423 件、この内訳の 2.6%
0%19.9%その他 27.3%

分野

  • Medicine94.7%
  • Engineering1.8%
  • Biochemistry, Genetics and Molecular Biology1.2%
  • Materials Science0.4%
  • Economics, Econometrics and Finance0.3%
  • Health Professions0.3%
  • その他1.3%

トピック

  • Coronary Interventions and Diagnostics13%
  • Acute Myocardial Infarction Research7.8%
  • Antiplatelet Therapy and Cardiovascular Diseases7.2%
  • Cardiac Imaging and Diagnostics6.3%
  • Cardiac Valve Diseases and Treatments5.9%
  • Cerebrovascular and Carotid Artery Diseases4.5%
  • その他55.3%

共著者

全論文

検索で開く
  1. Standardized Bleeding Definitions for Cardiovascular Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , - Circulation 2011 被引用: 4,423

  2. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

    著者: , , , , , , , , , , , , , , , , , - Circulation 2018 被引用: 933

  3. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple - Circulation 2018 被引用: 713

  4. Clinical End Points in Coronary Stent Trials

    著者: , , , , , , , , , , , , , , - Circulation 2007 被引用: 5,420

  5. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - Circulation 2019 被引用: 796

  6. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - European Heart Journal 2019 被引用: 572

  7. Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 被引用: 2,988

  8. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 1,898

  9. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Cavendish, Eugene Chung, Maja Cikes, Ira Dauber, Erwan Donal, Jean-Christophe Eicher, Peter Fail, James Flaherty, Xavier Freixa, Sameer Gafoor, Zachary Gertz, Robert Gordon, Marco Guazzi, Cesar Guerrero-Miranda, Deepak Gupta, Finn Gustafsson, Cyrus Hadadi, Emad Hakemi, Louis Handoko, Moritz Hass, Jorg Hausleiter, Christopher Hayward, Gavin Hickey, Scott Hummel, Imad Hussain, Richard Isnard, Chisato Izumi, Guillaume Jondeau, Elizabeth Juneman, Koichiro Kinugawa, Robert Kipperman, Bartek Krakowiak, Selim Krim, Joshua Larned, Gregory Lewis, Erik Lipsic, Anthony Magalski, Sula Mazimba, Jeremy Mazurek, Michele McGrady, Scott Mckenzie, Shamir Mehta, John Mignone, Hakim Morsli, Ajith Nair, Thomas Noel, James Orford, Kishan Parikh, Tiffany Patterson, Martin Penicka, Mark Petrie, Burkert Pieske, Martijn Post, Philip Raake, Alicia Romero, John Ryan, Yoshihiko Saito, Takafumi Sakamoto, Yasushi Sakata, Michael Samara, Kumar Satya, Andrew Sindone, Randall Starling, Jean-Noël Trochu, Bharathi Upadhya, Jan van der Heyden, Vanessa van Empel, Amit Varma, Amanda Vest, Tobias Wengenmayer ほか 4 名 - The Lancet 2022 被引用: 235

  10. Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2023 被引用: 174

  11. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple, Heather D. Fitter, Kachikwu Illoh, Kenneth J. Cavanaugh, Benjamin M. Scirica, Ilan Irony, Rachel E. Brown Kichline, Jonathan G. Levine, Anna Park, Leonard Sacks, Ana Szarfman, Ellis F. Unger, Lori Ann Wachter, Bram Zuckerman, Yale Mitchel, Douglas Peddicord, Thomas Shook, Bron Kisler, Charles L. Jaffe, Rhonda Bartley, David L. DeMets, MariJo Mencini, Cheri Janning, Steve Bai, John Lawrence, Ralph B. D’Agostino, Stuart Pocock - Journal of the American College of Cardiology 2018 被引用: 322

  12. Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2012 被引用: 1,662

  13. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials

    著者: , , , , , , , , , , , , , , , - Circulation 2014 被引用: 704

  14. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William J. Nicholson, Yoshinobu Onuma, Georgios Sianos, Satoru Sumitsuji, Etsuo Tsuchikane, Renu Virmani, Simon Walsh, Gerald S. Werner, Masahisa Yamane, Gregg W. Stone, Stéphane Rinfret, Gregg W. Stone - Circulation 2021 被引用: 290

  15. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

    著者: , , , , , , , , , , , , , , , , - JAMA 2016 被引用: 911

  16. Standardized End Point Definitions for Coronary Intervention Trials

    著者: , , , , , , , , , , , , , , , , , - European Heart Journal 2018 被引用: 311

  17. Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 被引用: 367

  18. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 1,007

  19. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott D. Solomon, Jean-Noël Trochu, Dirk J. Van Veldhuisen, Ralf Westenfeld, Martin B. Leon, Sanjiv J. Shah, on behalf of the REDUCE LAP-HF-II Investigators - Circulation 2022 被引用: 120

  20. Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ernest Spitzer - Circulation 2022 被引用: 74

  21. Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2004 被引用: 2,853

  22. Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease

    著者: , , , , , , , , , , , , , , , , , , , , , - Circulation 2011 被引用: 496

  23. Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2023 被引用: 24

  24. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2011 被引用: 734